References
- Aricò M, Valsecchi MG, Rizzari C, et al Long-term results of the AIEOP-ALL-95 Trial for Childhood Acute Lymphoblastic Leukemia: insight on the prognostic value of DNA index in the framework of Berlin-Frankfurt-Muenster based chemotherapy. J Clin Oncol 2008;26:283–289.
- Chen CY, Zimmerman RA, Faro S, Bilaniuk LT, Chou T, Molloy PT. Childhood leukemia: central nervous system abnormalities during and after treatment. AJNR Am J Neuroradiol 1996;17:295–310.
- Ochs JJ. Neurotoxicity due to central nervous system therapy for childhood leukemia. Am J Pediatr Hematol Oncol 1989;11:95–105.
- Ray M, Marwaha RK, Trehan A. Chemotherapy related fatal neurotoxicity during induction in acute lymphoblastic leukemia. Indian J Pediatr 2002;69:185–187.
- Aytac S, Yetgin S, Tavil B. Acute and long-term neurologic complications in children with acute lymphoblastic leukemia. Turk J Pediatr 2006;48:1–7.
- Flohr T, Scrauder A, Cazzaniga G, et al Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia. Leukemia 2008;22:771–782.
- Conter V, Bartram CR, Valsecchi MG, et al Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study. Blood 2010 Feb 12. [Epub ahead of print].
- Walker RW, Allen JC, Rosen G, Caparros B. Transient cerebral dysfunction secondary to high-dose methotrexate. J Clin Oncol 1986;4:1845–1850.
- Hinchey J, Chaves C, Appignani B. A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996;334:494–500.
- Kwon S, Koo J, Lee S. Clinical spectrum of reversible posterior leukoencephalopathy syndrome. Pediatr Neurol 2001;24:361–364.
- Antunes NL, Small TN, George D, Boulad F, Lis E. Posterior leukoencephalopathy syndrome may not be reversible. Pediatr Neurol 1999;20:241–243.
- Prasad N, Gulati S, Gupta RK, Kumar R, Sharma K, Sharma RH. Is reversible posterior leukoencephalopathy with severe hypertension completely reversible in all patients? Pediatr Nephrol 2003;18:1161–1166.
- D'Angelo P, Farruggia P, Lo Bello A, et al Reversible posterior leukoencephalopathy syndrome. Report of 2 simultaneous cases in children. J Pediatr Hematol Oncol 2006;28:177–181.
- Morris EB, Laningham FH, Sandlund JT, Khan RB. Posterior reversible encephalopathy syndrome in children with cancer. Pediatr Blood Cancer 2007;48:152–159.
- Lucchini G, Grioni D, Colombini A, et al Encephalopathy syndrome in children with hemato-oncological disorders is not always posterior and reversible. Pediatr Blood Cancer 2008;51:629–633.
- Vezmar S, Becker A, Bone U, Jachde U. Biochemical and clinical aspects of methotrexate neurotoxicity. Chemotherapy 2003;49:92–104.